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Abstract
Objective—To describe factors associated with provider-ordered influenza testing among 
hospitalized adults.
Design—Information on patient demographics, symptoms, and provider-ordered influenza 
testing were collected by questionnaire and chart review. We conducted prospective laboratory-
based surveillance using reverse-transcriptase polymerase chain reaction (RT-PCR), the gold-
standard for diagnosis of influenza, to determine how patient characteristics and provider-ordered 
testing impacted accurate influenza diagnosis.
Setting—One academic and three community hospitals in Davidson County, Tennessee, USA.
Participants—1422 adults ages 18 years and older with acute respiratory illness or non-
localizing fever.
Measurements—We compared characteristics of participants with and without provider-ordered 
testing for influenza using the Wilcoxon test and Pearson’s chi-square test. Multivariable logistic 
regression models identified factors predictive of provider-ordered influenza testing.
Results—Overall 28% (399/1422) of participants had provider-ordered influenza testing. Patients 
who were tested were younger than those not tested (58 ± 18 years vs. 66 ± 15 years, p < 0.001) 
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and more likely to have influenza-like illness (ILI, 71% vs. 49%, p < 0.001). ILI increased with 
decreasing age: 48% ≥ 65 years; 60% 50–64 years; and 63% 18–49 years. Among all patients, 
presence of ILI and younger age were independent predictors of provider-ordered testing. Among 
the 136 patients with RT-PCR confirmed influenza, ILI was the only significant predictor of 
provider-ordered testing (AOR 3.43, 95% CI 1.22–9.70).
Conclusion—Adults 65 years and older hospitalized with fever or respiratory symptoms during 
influenza season are less likely to have a provider-ordered influenza test than younger adults. 
Some, but not all, of this disparity is due to a lower likelihood of ILI presentation. Further 
strategies are needed to increase clinician awareness and testing in this vulnerable group.
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Introduction
Infections caused by influenza virus are associated with substantial morbidity and mortality 
for all age groups, with the highest rates of hospitalization and death in older adults [1–6]. 
Prompt recognition, diagnosis, and treatment is predicated upon a suitable case definition of 
influenza-like illness (ILI), conventionally defined by the Centers for Disease Control as 
fever (temperature ≥ 37.8°C) and cough and/or sore throat [7]. However, this definition has 
several limitations in older adults due to both co-morbid conditions and immune senescence 
(aging of the immune system). Adults ≥ 65 years may have an attenuated febrile response, 
potentially due to altered thermoregulatory responses or lower baseline core body 
temperatures, leading some to suggest revised criteria with a lower fever threshold for older 
adults with suspected influenza [8–12]. Recognition of influenza in older adults may be 
further complicated by cognitive deficits that limit ability to communicate symptoms and 
exacerbations of chronic conditions, particularly cardiac and pulmonary disease, that may 
dominate the clinical presentation. The impact of these differences on provider-ordered 
influenza testing is not well known.
We examined the demographic and clinical characteristics of inpatients that underwent 
provider-ordered influenza testing and compared them to those who were not tested to 
examine what factors influence influenza testing. Since all patients underwent study-ordered 
RT-PCR testing for influenza, patients with study-confirmed influenza were compared with 
those who underwent provider-ordered testing to examine what impact testing behaviors had 
on diagnosis and treatment of influenza virus infections across age groups, particularly in 
the ≥ 65 year old population.
Methods
Study Design
Adults hospitalized with symptoms of acute respiratory illness or non-localizing fever at 
four hospitals in Davidson County, Tennessee were enrolled during each influenza season 
from November 2006 to April 2012 with the primary goal of evaluating the effectiveness of 
influenza vaccine for the prevention of hospitalization. The influenza season was defined as 
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weeks including all laboratory-confirmed influenza infections in the clinical and research 
laboratories at Vanderbilt University Medical Center. Two hospitals collected surveillance 
data during the first two influenza seasons, and four hospitals (one academic and three 
community hospitals) collected data from 2008 to 2012. The 2009 pandemic season was 
excluded from analyses.
After consent and enrollment in the study, the patient or his/her caregiver completed a 
questionnaire regarding presenting symptoms and influenza vaccination status. Patients with 
respiratory illness or fever were further classified as presenting with ILI based on symptoms 
of cough and/or sore throat and fever (temperature ≥ 37.8°C or subjective report of fever or 
feverishness). Healthcare providers were unaware patients were enrolled in the study, hence 
any inpatient influenza testing by providers was ordered as part of usual care. Medical 
records were reviewed using a standardized form to obtain demographic information, history 
of comorbid medical conditions, results of provider-initiated diagnostic studies, and 
discharge diagnoses. Provider-ordered influenza tests included rapid antigen detection, 
polymerase chain reaction (PCR), or viral culture tested in the clinical laboratory of their 
respective institution.
The study protocol was approved by the Institutional Review Board of Vanderbilt University 
Medical Center and the private Institutional Review Boards Sterling and Western.
Study Population
Patients hospitalized with the following admission diagnoses (International Classification of 
Diseases, 9th Revision) were enrolled: pneumonia (480–486), upper respiratory infection 
(465), bronchitis (466), influenza (487), chronic obstructive pulmonary disease (490 to 492; 
496), asthma (493), viral illness (079.9), dyspnea (786), acute respiratory failure (518.81), 
pneumonitis due to solids/liquids (507), or fever (780.6) without localizing symptoms or if 
patients presented with any of the following symptoms: cough, non-localizing fever, 
shortness of breath, sore throat, and nasal congestion or coryza. Adults 50 years of age and 
older were enrolled for the first two influenza seasons, and adults ≥ 18 years were enrolled 
from 2008 onwards.
Laboratory Methods
Mid-turbinate nose and throat swabs were obtained from each patient at the time of 
enrollment and tested for influenza virus in the research laboratory by real-time reverse-
transcriptase polymerase chain reaction (RT-PCR) using primers and probes designed by the 
Centers for Disease Control and Prevention. Confirmed study-ordered influenza positive 
cases were defined as positive RT-PCR on duplicate testing of the individual’s sample.
Analysis
We compared characteristics of subjects with and without provider-ordered testing for 
influenza using the Wilcoxon test and Pearson’s chi-square test for continuous and 
categorical variables, respectively. The following variables were pre-specified as potential 
factors impacting provider-ordered influenza testing: age (as a continuous variable), race, 
insurance, underlying medical comorbidities (cardiac disease, COPD/asthma, and other 
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high-risk conditions), ILI, self-reported vaccination status, and study year. Two multivariable 
logistic regression models were conducted to assess associations between pre-specified 
factors, provider-ordered influenza testing and study-ordered influenza positive patients. 
Adjusted odds ratios and 95% CIs were reported. All data analyses were conducted using the 
statistical computing program R version 3.4.1.
Results
Patient Characteristics
A total of 2556 adults hospitalized with symptoms of acute respiratory illness or non-
localizing fever were eligible for the study, of whom 1422 (56%) consented to participate 
(table 1). Although the average age of those who participated was lower than those who 
declined participation (63 vs. 67 years; p < 0.001), enrolled participants were similar to 
those who declined participation in regard to sex (60% vs. 57% female) and race (39% vs. 
40% white). Of the 1422 enrolled participants, 48% were aged 65 years and greater, 39% 
were white and 10% were black.
Provider-ordered influenza testing
Provider-ordered influenza testing included antigen detection, viral culture, PCR, or a 
combination and was ordered in only 28% (399/1422) of enrolled subjects presenting with 
an acute respiratory illness or fever. Overall 41% (231/561) of participants receiving care in 
the academic hospital had provider-ordered testing for influenza compared to only 20% 
(168/861) in the community setting. Of the total of 450 provider-ordered tests, 387 (97.0%) 
were antigen detection, 29 (7.3%) were viral culture, and 34 (8.5%) were PCR detection. 
Among those who had provider ordered testing, 8% (32/399) of patients had clinical 
laboratory confirmed influenza, representing 2% (32/1422) of the total population. Among 
those who had research laboratory testing, 10% (136/1422) of patients had research 
laboratory confirmed influenza, including 77 patients tested for influenza by their physician 
and 59 patients not tested, with 43% (59/136) of the patients with confirmed influenza by 
RT-PCR not tested by their providers. There was no significant variation in proportion of 
patients tested by month or season during the influenza seasons included in this study [13].
Provider-ordered testing was more common among younger patients and in those presenting 
with ILI (table 2). The mean age of those with vs. without provider-ordered influenza testing 
was 58 ± 18 years vs. 66 ± 15 years, respectively (p < 0.001). Among the patients who 
presented with ILI, the mean age of those with vs. without provider-ordered influenza 
testing was 55 ± 10 years vs. 63 ± 9 years, respectively (p = 0.027). Duration of symptoms 
on admission was similar in those with provider-ordered testing compared to those who were 
not tested (4.2 ± 7.0 days vs. 4.8 ± 7.5 days, p = 0.15).
Those with provider-ordered influenza testing were more likely to have presented with fever 
(73% tested vs. 44% not tested, p < 0.001) and ILI (71% tested vs. 49% not tested, p < 
0.001). Among all patients, ILI was less common in older patients (48% ≥ 65 years; 60% 
50–64 years; and 63% 18–49 years). Among patients with study-confirmed influenza, ILI 
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was also less common in older patients (74% ≥ 65 years; 83% 50–64 years; and 81% 18–49 
years).
Provider-ordered testing did not differ by patient gender or race. A significantly lower 
proportion of patients with heart disease and lung disease, including COPD or asthma, 
underwent provider-ordered influenza testing when compared to those without these 
conditions (36% vs. 64%, p < 0.001 and 45% vs. 55%, p < 0.001, respectively). There was 
no significant difference in comorbid cardiac or pulmonary disease between provider tested 
and not tested patients who presented with ILI. A greater proportion of those not tested for 
influenza reported having had been vaccinated compared to those tested (69% vs. 61%, p = 
0.005). The distribution of discharge diagnoses for those tested vs. not tested for influenza 
differed significantly (p<0.001): while both groups were primarily diagnosed with 
pneumonia (37% not tested vs. 41% tested), those not tested for influenza were discharged 
with proportionally more diagnoses of COPD/asthma (30% vs. 20%) and cardiac disease 
(11% vs. 3%).
In patients presenting with an acute respiratory illness during influenza season, independent 
factors associated with provider-ordered influenza testing in a multivariable logistic 
regression model were younger age (AOR 2.02, 95% CI 1.55–2.63), no history of lung 
disease (AOR 1.68, 95% CI 1.26–2.24) and symptoms of ILI (AOR 2.22, 95% CI 1.71–2.89) 
(table 3). In a model of only those patients with confirmed influenza by study-ordered 
influenza testing, only ILI was a significant independent factor associated with provider-
ordered influenza testing (AOR 3.43, 95% CI 1.22–9.70). Finally, those with provider-
ordered testing were more likely to receive treatment with antivirals (6.8% vs. 0.2%, p < 
0.001).
Discussion
In our study, provider-ordered testing for influenza was uncommon, and nearly half of the 
patients with confirmed influenza by RT-PCR did not have testing ordered by their 
providers. Patients who were tested for influenza by their providers tended to be younger 
and to have presented with ILI. A lower proportion of older adults presented with ILI 
compared to younger adults, consistent with prior studies examining clinical case definitions 
for influenza [8–10, 14, 15]. In our analysis of independent factors associated with influenza 
testing, age was negatively correlated with provider-ordered testing. For those patients who 
had study confirmed influenza by RT-PCR, only ILI was correlated with provider-ordered 
testing. The known lack of ILI symptoms in older adults may lead to missed influenza 
diagnosis and missed opportunities for treatment. However, we found that even in the subset 
of older patients who presented with ILI, fewer had provider-ordered influenza testing than 
younger adults, and though the interaction between age and ILI was not statistically 
significant it suggests that ILI presentation alone may not account for decreased testing.
Those with cardiac and/or pulmonary disease were also less likely to have provider-ordered 
influenza testing, which may simply reflect the many alternative diagnoses that exist for 
respiratory illness in patients with underlying disease. However, it is also conceivable that 
influenza-associated exacerbations of cardiac or pulmonary conditions are underappreciated 
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in patients with complex presentations, which is a potential target for physician education 
and should be considered in guidelines for testing and treatment of influenza in this 
population. Patients who reported having received the influenza vaccine were less likely to 
be tested as well, though this was not a significant association in our model. In the United 
States, vaccination of adults for influenza tends to increase with increasing age, with adults 
over 65 years of age having the highest vaccination rates [16]. It is uncertain if providers 
consistently assess for and use vaccination information to guide clinical decisions, but this 
might contribute to lower rates of provider-ordered testing in more highly vaccinated 
populations. Additionally, studies have demonstrated an attenuation of influenza symptoms 
in adults who have been vaccinated, which may explain some differences in clinical 
presentation and lead to less provider-ordered testing in patients who were vaccinated [17, 
18]
The proportion of patients tested at the academic center in our study was more than double 
that tested in the community hospitals, suggesting a difference in practices across inpatient 
settings that should be further examined. Another recent study of patients at an academic 
medical center observed high rates of testing in adults over 75 years of age and increased 
testing in those with high-risk conditions compared those without comorbidities [19]. The 
conflicting results of these two studies may reflect differences in testing practices in 
academic vs. community settings and between academic centers, which could be due to 
clinician factors, institutional practices, or test availability. These findings suggest the need 
to examine strategies that result in increased recognition of the need for testing.
A major concern regarding lower rates of influenza testing in older adults is that clinicians 
are underdiagnosing influenza in a population with substantial morbidity and mortality that 
could be mitigated by early antiviral treatment [1, 2, 20–22]. A better understanding of the 
factors involved in provider-ordered testing is needed to determine the barriers to early 
identification and treatment of infection. Early antiviral treatment improves outcomes and 
reduces rates of bacterial infection and other complications of respiratory viral illness, and 
positive tests can furthermore minimize overuse of antibiotics and unnecessary diagnostic 
workup [20–24].
Despite the current recommendation to use influenza antivirals within 48 hours of symptom 
onset, our study indicated that <3% of older patients presenting with an acute respiratory 
illness and only 11% of those with study-confirmed influenza received antivirals [13, 23]. 
Older adults may present later in illness with complications associated with influenza, 
leading clinicians to forego testing and treatment. This delay could also have implications 
for infection control. Activation of infection control measures that accompany provider-
ordered influenza testing reduces nosocomial spread of infection, a benefit which is lost if 
clinicians do not identify those at risk in the elderly population.
An important consideration after decision to test for influenza is the choice of influenza 
diagnostic test employed. Rapid antigen tests have been shown to have poor sensitivity in 
hospitalized older adults, and previous high rates of false negatives may have led physicians 
to order fewer tests [24, 25]. Despite this, the majority of influenza tests ordered in our study 
were antigen detection, which may lead to missed cases and underdiagnosis of influenza in 
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this population. The challenge of influenza diagnosis in hospitalized older adults is to not 
only identify cases clinically, but select an appropriately sensitive diagnostic test such as RT-
PCR. This test is more sensitive than rapid diagnostic tests employed in the routine 
diagnostic laboratory, though also typically more costly which may limit its use [24, 25].
There are limitations to this study. The enrolled subjects were slightly younger than the 
unenrolled subjects, and thus the data may actually underrepresent cases of influenza in 
older adults. Subjects were enrolled at hospitals in Davidson County, TN and the 
conclusions may not be generalizable to other care settings including outpatient practices. 
Self-report of vaccination may not reflect actual immunization, although self-report has been 
demonstrated by others to be both reliable and readily obtainable [26]. Finally, increased 
availability of new more sensitive and rapid molecular diagnostics may impact testing 
practices in ways that were not examined in this manuscript.
Conclusions
Despite being at high risk for morbidity and mortality from influenza virus infection and 
sequelae, hospitalized older adults were tested for influenza less often than their younger 
counterparts, with testing performed in a minority of patients. No single factor accounts for 
decreased provider-ordered testing in this population, though differences in presentation 
including less influenza-like illness, attenuation of symptoms by vaccination, and higher 
burden of underlying cardiac and pulmonary disease may impact the decision of the provider 
to perform influenza testing. Further strategies are needed to increase clinician 
understanding of the challenges in clinically identifying influenza in older adults, as well as 
the limitations of diagnostic tests, to better diagnose and treat cases of influenza in this 
vulnerable population.
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Impact statement
We certify that this work is novel. While many have recognized the challenge of prompt 
recognition, diagnosis, and treatment of influenza virus infection in older adults, an 
examination of the demographic and clinical characteristics that influence influenza 
testing is lacking in the literature. Our study confirms that older adults are being 
undertested and underdiagnosed with influenza and identifies the clinical features 
complicating diagnosis for providers, thus highlighting areas of educational need and 
improvement.
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Table 1
Characteristics of adults hospitalized with symptoms of respiratory illness or non-localizing fever by consent 
status.
Characteristic All patients (N = 2556) N (%)
No Consent (N=1134) N 
(%) Consent (N=1422) N (%)
P-value (consented 
vs. not)
Age, years (mean ± SD) 65 ± 17 67 ± 17 63 ± 17 < 0.001
Age group, years
18–64 1204 (47) 464 (41) 740 (52) <0.001
65+ 1352 (53) 670 (59) 682 (48)
Gender*
Female 1502 (59) 647 (57) 855 (60) 0.003
Male 1046 (41) 479 (42) 567 (40)
Race
White 1009 (39) 448 (40) 561 (39) 0.96
Black 272 (11) 125 (11) 147 (10)
Other 1275 (50) 561 (49) 714 (50)
Insurance**
No 87 (4) 25 (4) 62 (4) 0.057
Yes 1886 (94) 554 (95) 1332 (94)
Unknown 31 (2) 3 (1) 28 (2)
Fever
No 1141 (45) 470 (41) 671 (47) <0.001
Yes 992 (39) 248 (22) 744 (52)
Unknown 423 (17) 416 (37) 7 (1)
*N = 2548;
**N = 2004
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Table 3
Independent factors associated with provider-ordered influenza testing among all adults hospitalized with 
symptoms of acute respiratory illness or non-localizing fever and among only those adults with research 
laboratory-confirmed influenza.
All patients (N = 1422) AOR (95% CI) Research flu test + patients (N = 1422) AOR (95% CI)
Age 2.02 (1.55–2.63) 1.47 (0.65–3.37)
No lung disease 1.68 (1.26–2.24) 1.65 (0.68–4.00)
ILI 2.22 (1.71–2.89) 3.43 (1.22–9.70)
Variables included in the multivariable model were age (as a continuous variable), race, insurance, underlying medical comorbidities (cardiac 
disease, COPD/asthma, and other high-risk conditions), ILI, self-reported vaccination status, and study year.
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